Comment on ‘Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab'
Main Authors: | , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
2011
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3241566/ |